Biocon sends reminder to shareholders to claim unclaimed dividends by August 20, 2026
Biocon Limited reminds shareholders to claim unclaimed dividends for seven consecutive years, particularly from FY 2018-19, to avoid transfer to the IEPF. Final dividends were declared for FYs 2018-19 (July 26, 2019), 2021-22 (July 28, 2022), 2022-23 (August 11, 2023), 2023-24 (August 9, 2024), and 2024-25 (August 8, 2025). Shareholders must claim by August 20, 2026. Unpaid dividends and shares up to FY18 have already been transferred to IEPF.
The announcement is a routine notification regarding unclaimed dividends and is unlikely to have a significant impact on the company's operations or stock price.
The announcement is a procedural reminder to shareholders regarding unclaimed dividends and does not contain any positive or negative financial information.
Biocon Limited has issued a reminder to its shareholders regarding unclaimed dividends for seven consecutive years, specifically concerning the financial year 2018-19. The company urges shareholders to claim their dividends to avoid the transfer of both the dividends and underlying shares to the Investor Education and Protection Fund (IEPF). A letter dated May 19, 2026, was dispatched to shareholders who have not claimed their dividends, emphasizing compliance with SEBI regulations and the IEPF Authority Rules, 2016. The company has declared final dividends for the financial years 2018-2019 (declared on July 26, 2019), 2021-2022 (declared on July 28, 2022), 2022-2023 (declared on August 11, 2023), 2023-2024 (declared on August 9, 2024), and 2024-2025 (declared on August 8, 2025). No dividends were declared for the financial years 2019-20 and 2020-21. Shareholders must claim their unclaimed dividends no later than August 20, 2026, after which the equity shares will be transferred to the IEPF Authority. The company has provided instructions for claiming the dividends, including submitting necessary documents to Biocon or KFin Technologies Limited, the Registrar and Share Transfer Agent (RTA). The company also clarified that dividends and shares up to the financial year 2017-18 have already been transferred to the IEPF authority.
What to do with a filing like this
Biocon Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.